DDD Stock Analysis: 3D Systems | NYSE
Computer Hardware | NYSE, USA | Market Cap: 469m USD | 12M Return: 68.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 11.5M
Qual. Beats: 1
Rev. Trend: -99.1%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
3D Systems Corporation (NYSE: DDD) is a global provider of 3D printing and digital manufacturing solutions, operating across the Americas, Europe, the Middle East, Africa, Asia Pacific, and Oceania. The company is organized into two reportable segments: Healthcare Solutions and Industrial Solutions. Its technology portfolio spans multiple 3D printing methods, including stereolithography (SLA), selective laser sintering, direct metal printing, MultiJet printing, and ColorJet printing, supported by a range of print materials such as plastics, nylon, metals, composites, elastomers, wax, and biocompatible materials.
Beyond printers and materials, the company offers digital design tools (software, scanners, haptic devices) and software platforms like 3D Sprint, 3DXpert, and the Oqton manufacturing operating system for managing additive manufacturing workflows. It also provides maintenance, training, and advanced manufacturing services. Its customer base spans industries such as healthcare, dental, automotive, aerospace, defense, energy, electronics, semiconductors, and education, reached through a direct sales force, channel partners, and distributors. Founded in 1986 and headquartered in Rock Hill, South Carolina, 3D Systems is a small-cap company classified within the Industrials sector.
- Healthcare revenue growth led by dental and bioprinting demand
- Industrial segment weakness pressures margins amid intense additive manufacturing competition
- Divestiture proceeds accelerate debt paydown and strengthen capital allocation flexibility
| Net Income: 62.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.14 > 0.02 and ΔFCF/TA -1.93 > 1.0 |
| NWC/Revenue: 56.01% < 20% (prev 59.73%; Δ -3.72% < -1%) |
| CFO/TA -0.12 > 3% & CFO -61.3m > Net Income 62.4m |
| Net Debt (112.5m) to EBITDA (108.3m): 1.04 < 3 |
| Current Ratio: 2.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (143.3m) vs 12m ago 8.15% < -2% |
| Gross Margin: 33.93% > 18% (prev 36.12%; Δ -2.19% > 0.5%) |
| Asset Turnover: 70.75% > 50% (prev 74.01%; Δ -3.26% > 0%) |
| Interest Coverage Ratio: 12.95 > 6 (EBIT TTM 87.4m / Interest Expense TTM 6.75m) |
| A: 0.42 (Total Current Assets 340.7m - Total Current Liabilities 123.4m) / Total Assets 513.1m |
| B: -2.61 (Retained Earnings -1.34b / Total Assets 513.1m) |
| C: 0.16 (EBIT TTM 87.4m / Avg Total Assets 548.2m) |
| D: 0.84 (Book Value of Equity 234.3m / Total Liabilities 278.8m) |
| Altman-Z'' = -3.76 = D |
| DSRI: 0.92 (Receivables 86.2m/104.7m, Revenue 387.9m/431.8m) |
| GMI: 1.06 (GM 36.12% / 33.93%) |
| AQI: 1.19 (AQ_t 0.14 / AQ_t-1 0.12) |
| SGI: 0.90 (Revenue 387.9m / 431.8m) |
| TATA: 0.24 (NI 62.4m - CFO -61.3m) / TA 513.1m) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of July 11, 2026, the stock is trading at USD 3.07 with a total of 2,391,530 shares traded. Over the past week, the price has changed by +9.64%, over one month by +6.23%, over three months by +59.90% and over the past year by +68.68%.
Current recommended Stop Loss: 2.50 (which is 18.6% or 2.5 ATR below the current price).
3D Systems has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold DDD.
- StrongBuy: 1
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 4 | 30.3% |
P/E Trailing = 6.3778
P/E Forward = 22.5225
P/S = 1.2085
P/B = 1.9516
P/EG = 0.8503
Revenue TTM = 387.9m USD
EBIT TTM = 87.4m USD
EBITDA TTM = 108.3m USD
Long Term Debt = 86.8m USD (from longTermDebt, last quarter)
Short Term Debt = 14.9m USD (from shortTermDebt, last quarter)
Debt = 197.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 53.4m
Net Debt = 112.5m USD (calculated: Debt 197.6m - CCE 85.1m)
Enterprise Value = 581.3m USD (468.8m + Debt 197.6m - CCE 85.1m)
Interest Coverage Ratio = 12.95 (Ebit TTM 87.4m / Interest Expense TTM 6.75m)
EV/FCF = -8.25x (Enterprise Value 581.3m / FCF TTM -70.5m)
FCF Yield = -12.12% (FCF TTM -70.5m / Enterprise Value 581.3m)
FCF Margin = -18.16% (FCF TTM -70.5m / Revenue TTM 387.9m)
Net Margin = 16.10% (Net Income TTM 62.4m / Revenue TTM 387.9m)
Gross Margin = 33.93% ((Revenue TTM 387.9m - Cost of Revenue TTM 256.3m) / Revenue TTM)
Gross Margin QoQ = 35.42% (prev 30.28%)
Tobins Q-Ratio = 1.13 (Enterprise Value 581.3m / Total Assets 513.1m)
Interest Expense / Debt = 3.41% (Interest Expense 6.75m / Debt 197.6m)
Taxrate = 20.11% (15.7m / 78.0m)
NOPAT = 69.8m (EBIT 87.4m * (1 - 20.11%))
Current Ratio = 2.76 (Total Current Assets 340.7m / Total Current Liabilities 123.4m)
Debt / Equity = 0.84 (Debt 197.6m / totalStockholderEquity, last quarter 234.3m)
Debt / EBITDA = 1.04 (Net Debt 112.5m / EBITDA 108.3m)
Debt / FCF = -1.60 (negative FCF - burning cash) (Net Debt 112.5m / FCF TTM -70.5m)
Total Stockholder Equity = 234.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.39% (Net Income 62.4m / Total Assets 513.1m)
RoE = 26.66% (Net Income TTM 62.4m / Total Stockholder Equity 234.3m)
RoCE = 27.21% (EBIT 87.4m / Capital Employed (Equity 234.3m + L.T.Debt 86.8m))
RoIC = 18.12% (NOPAT 69.8m / Invested Capital 385.2m)
WACC = 11.51% (E(468.8m)/V(666.4m) * Re(15.21%) + D(197.6m)/V(666.4m) * Rd(3.41%) * (1-Tc(0.20)))
Discount Rate = 15.21% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -11.11 | Cagr: 4.41%
[DCF] Fair Price = unknown (Cash Flow -70.5m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.04 | # QB: 1
Revenue Correlation: -99.09 | Revenue CAGR: -10.42% | SUE: 0.75 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.05 | Chg30d=N/A | Revisions=+50% | Analysts=4
EPS next Quarter (2026-09-30): EPS=-0.05 | Chg30d=N/A | Revisions=+17% | Analysts=4
EPS current Year (2026-12-31): EPS=-0.14 | Chg30d=N/A | Revisions=+50% | GrowthEPS=+60.8% | GrowthRev=+0.6%
EPS next Year (2027-12-31): EPS=-0.13 | Chg30d=N/A | Revisions=+57% | GrowthEPS=+12.1% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: +69% (up=12, down=1)